ReWalk Robotics Ltd. (RWLK)

$0.9201

+0.00 (+0.01%)
Rating:
Recommendation:
Buy
Symbol RWLK
Price $0.9201
Beta 2.750
Volume Avg. 0.28M
Market Cap 57.515M
Shares () -
52 Week Range 0.81-2.78
1y Target Est -
DCF Unlevered RWLK DCF ->
DCF Levered RWLK LDCF ->
ROE -16.81% Sell
ROA -15.58% Sell
Operating Margin -
Debt / Equity 5.65% Neutral
P/E -
P/B 0.67 Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest RWLK news


Mr. Lawrence Jasinski
Healthcare
Medical Devices
NASDAQ Capital Market

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.